PortfoliosLab logoPortfoliosLab logo
OPAD vs. CCCC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OPAD vs. CCCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Offerpad Solutions Inc. (OPAD) and C4 Therapeutics, Inc. (CCCC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OPAD achieves a -68.02% return, which is significantly lower than CCCC's 82.20% return.


OPAD

1D
-6.75%
1M
-26.84%
6M
-62.06%
YTD
-68.02%
1Y
-68.28%
3Y*
-68.01%
5Y*
-69.56%
10Y*
ALL TIME*
-65.84%

CCCC

1D
-4.92%
1M
-19.07%
6M
83.16%
YTD
82.20%
1Y
64.15%
3Y*
-2.11%
5Y*
-39.56%
10Y*
ALL TIME*
-29.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$9.69M$11.72M$12.55M
$176.09K$234.55K$395.69K

OPAD vs. CCCC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
OPAD
Offerpad Solutions Inc.
-68.02%-57.54%-72.20%48.39%-92.80%-41.82%0.24%
CCCC
C4 Therapeutics, Inc.
82.20%-46.94%-36.28%-4.24%-81.68%-2.81%13.65%

Correlation

The correlation between OPAD and CCCC is 0.27, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.27

Correlation (3Y)
Balances recent behavior with more history.

0.25

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.26

Correlation (All Time)
Calculated using the full available price history since Dec 11, 2020

0.25

Fundamentals

Market Cap

OPAD:

$11.99M

CCCC:

$384.77M

EPS

OPAD:

-$1.08

CCCC:

-$1.11

PS Ratio

OPAD:

0.30

CCCC:

11.38

PB Ratio

OPAD:

3.90

CCCC:

1.87

Total Revenue (TTM)

OPAD:

$487.19M

CCCC:

$28.71M

Gross Profit (TTM)

OPAD:

$37.09M

CCCC:

$26.90M

EBITDA (TTM)

OPAD:

-$29.30M

CCCC:

-$107.31M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OPAD vs. CCCC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

OPAD
OPAD Risk / Return Rank: 3030
Overall Rank
OPAD Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
OPAD Sortino Ratio Rank: 4141
Sortino Ratio Rank
OPAD Omega Ratio Rank: 3939
Omega Ratio Rank
OPAD Calmar Ratio Rank: 1616
Calmar Ratio Rank
OPAD Martin Ratio Rank: 2525
Martin Ratio Rank

CCCC
CCCC Risk / Return Rank: 7171
Overall Rank
CCCC Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
CCCC Sortino Ratio Rank: 7777
Sortino Ratio Rank
CCCC Omega Ratio Rank: 7171
Omega Ratio Rank
CCCC Calmar Ratio Rank: 7272
Calmar Ratio Rank
CCCC Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

OPAD vs. CCCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Offerpad Solutions Inc. (OPAD) and C4 Therapeutics, Inc. (CCCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OPADCCCCDifference
Sharpe ratioReturn per unit of total volatility

-1.07

Sortino ratioReturn per unit of downside risk

-1.54

Omega ratioGain probability vs. loss probability

1.03

1.20

-0.17

Calmar ratioReturn relative to maximum drawdown

-0.74

1.35

-2.08

Martin ratioReturn relative to average drawdown

-0.92

2.57

-3.49

OPAD vs. CCCC - Sharpe Ratio Comparison

The current OPAD Sharpe Ratio is -0.35, which is lower than the CCCC Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of OPAD and CCCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OPAD vs. CCCC - Drawdown Comparison

The maximum OPAD drawdown since its inception was -99.87%, roughly equal to the maximum CCCC drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for OPAD and CCCC.


Loading charts...

Drawdown Indicators


OPADCCCCDifference

Max Drawdown

Largest peak-to-trough decline

-99.87%

-97.82%

-2.05%

Max Drawdown (1Y)

Largest decline over 1 year

-93.79%

-52.10%

-41.69%

Max Drawdown (3Y)

Largest decline over 3 years

-97.03%

-90.00%

-7.03%

Max Drawdown (5Y)

Largest decline over 5 years

-99.87%

-97.82%

-2.05%

Current Drawdown

Current decline from peak

-99.87%

-93.11%

-6.76%

Average Drawdown

Average peak-to-trough decline

-82.51%

-72.40%

-10.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

74.79%

27.21%

+47.58%

Volatility

OPAD vs. CCCC - Volatility Comparison

Offerpad Solutions Inc. (OPAD) has a higher volatility of 26.05% compared to C4 Therapeutics, Inc. (CCCC) at 18.35%. This indicates that OPAD's price experiences larger fluctuations and is considered to be riskier than CCCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OPADCCCCDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.05%

18.35%

+7.70%

Volatility (6M)

Calculated over the trailing 6-month period

62.05%

64.03%

-1.98%

Volatility (1Y)

Calculated over the trailing 1-year period

198.91%

97.17%

+101.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

132.10%

117.75%

+14.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.62%

112.13%

+12.49%

Dividends

OPAD vs. CCCC - Dividend Comparison

Neither OPAD nor CCCC has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OPAD vs. CCCC - Financials Comparison

This section allows you to compare key financial metrics between Offerpad Solutions Inc. and C4 Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


OPAD and CCCC have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OPAD has higher volatility (26.05%) compared to CCCC (18.35%). In terms of maximum drawdown, OPAD dropped -99.87% vs CCCC's -97.82%.

CCCC currently has the higher Sharpe Ratio (0.72 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OPAD and CCCC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer